Charlotte, NC 的 卵巢癌 臨床試驗
12 項針對 卵巢癌 的研究正在 Charlotte（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
招募中1 期
- Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville · 距離 13 英里
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
招募中2 期
- Atrium Health Levine Cancer Institute /ID# 274557, Charlotte
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
招募中3 期
- Levine Cancer Center, Charlotte
- Novant Presbyterian Hospital, Charlotte
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
招募中1/2 期
- Research Site, Charlotte
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
招募中3 期
- Levine Cancer Institute, Charlotte
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
招募中1 期
- Atrium Health - Wake Forest, Charlotte
A Study of DM002 in Patients With Advanced Solid Tumors
招募中1/2 期
- Carolina BioOncology Institute, LLC, Huntersville · 距離 13 英里
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
招募中1/2 期
- Clinical Trial Site, Huntersville · 距離 13 英里
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
招募中2 期
- GSK Investigational Site, Charlotte
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- Carolina BioOncology Institute, Huntersville · 距離 13 英里
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
招募中1/2 期
- Levine Cancer Institute (LCI)- Atrium Health, Charlotte
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, Huntersville · 距離 13 英里
其他城市的 卵巢癌 試驗
- Houston, TX89 項研究
- New York City, NY69 項研究
- Boston, MA61 項研究
- Los Angeles, CA50 項研究
- Nashville, TN49 項研究
- Arlington, VA46 項研究
- Philadelphia, PA44 項研究
- Columbus, OH39 項研究
- St. Louis, MO38 項研究
- Chicago, IL36 項研究
- San Antonio, TX31 項研究
- Cleveland, OH30 項研究
Charlotte 的其他研究
- 癌症（所有類型）27 項研究
- 乳癌22 項研究
- 多發性骨髓瘤21 項研究
- 非小細胞肺癌19 項研究
- 急性髓系白血病16 項研究
- 肥胖症16 項研究
- 過重15 項研究
- 大腸直腸癌13 項研究
- 心臟衰竭11 項研究
- 轉移性癌症11 項研究
- 頭頸部鱗狀細胞癌10 項研究
- 慢性阻塞性肺病9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。